Pfizer is going to fire 2,000 salesmen, 20% of its domestic sales force. Lehman Bros estimated that the move could save $440 million a year.
The company’s reasoning would appear to be that as more of its drugs go "off patent" and generic competition for these drugs is allowed into the market, the revenue yield to the company will drop.
Pfizer’s annual revenue is about $50 billion. Its operating income last year was about $14 billion. Although the stock is down from about $38 in early 2004, at $27 it is very near its 52-week high.
As the market gets tougher, it is not unfair to assume that having a larger number of sales people in the market to keep share would make sense.
Since Pfizer is not electing to do that, the move may signal that its problem with generics and it new drug pipeline issues are worse than the markets think.
Douglas A. McIntyre can be reached at [email protected]. He does not own securities in companies that he writes about
Take Charge of Your Retirement: Find the Right Financial Advisor For You in Minutes (Sponsor)
Retirement planning doesn’t have to feel overwhelming. The key is finding professional guidance—and we’ve made it easier than ever for you to connect with the right financial advisor for your unique needs.
Here’s how it works:
1️ Answer a Few Simple Questions
Tell us a bit about your goals and preferences—it only takes a few minutes!
2️ Get Your Top Advisor Matches
This tool matches you with qualified advisors who specialize in helping people like you achieve financial success.
3️ Choose Your Best Fit
Review their profiles, schedule an introductory meeting, and select the advisor who feels right for you.
Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
